Related Experiment Video
Updated: Jun 3, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Vascular calcification in patients with chronic kidney disease: types, clinical impact and pathogenesis
Pablo Román-García1, Minerva Rodríguez-García, Iván Cabezas-Rodríguez
1Bone and Mineral Research Unit, Hospital Universitario Central de Asturias, Instituto Reina Sofía de Investigación, REDinREN del ISCIII, Universidad de Oviedo, Oviedo, Spain.
Insights
Vascular calcification, a key factor in cardiovascular disease mortality for chronic kidney disease patients, is linked to bone loss. Controlling phosphorus levels is crucial for managing this condition.
Area of Science:
- Nephrology
- Cardiology
- Bone Metabolism
Background:
- Vascular calcification is a significant contributor to cardiovascular disease mortality in chronic kidney disease (CKD) patients.
- It is influenced by traditional and uremia-related risk factors and affects arteries of various sizes.
- Vascular calcification shares pathogenic pathways with bone loss and fractures in both CKD and general populations.
Purpose of the Study:
- To explore the complex mechanisms underlying vascular calcification in CKD.
- To highlight the role of phosphorus and bone-related factors in vascular calcification.
- To review current and emerging strategies for controlling vascular calcification.
Main Methods:
- Review of existing literature on vascular calcification in CKD.
- Analysis of risk factors, including traditional and uremia-related factors.
- Examination of the interplay between vascular calcification and bone metabolism.
Main Results:
- Vascular calcification is a multifactorial process involving traditional and uremia-related risk factors.
- Hyperphosphatemia is a primary target for controlling vascular calcification.
- Emerging strategies targeting bone resorption and mineralization show potential but require further investigation.
Conclusions:
- Vascular calcification is a complex condition with significant implications for CKD patient mortality.
- Effective management requires addressing hyperphosphatemia and understanding the bone-vascular axis.
- Further research is needed to elucidate the intricate mechanisms and validate novel therapeutic approaches.
Abstract:
Vascular calcification plays a major role in cardiovascular disease, which is one of the main causes of mortality in chronic kidney disease patients. Vascular calcification is determined by prevalent traditional and uraemia-related (non-traditional) risk factors. It occurs mainly in the arteries, which are classified into three types according to their size and structural characteristics. In addition, vascular calcification has been associated with bone loss and fractures in chronic kidney disease patients and the general population, stressing the fact that both disorders can share pathogenetic pathways. The strategies to control vascular calcification involve several measures, chief among them the control of hyperphosphataemia. Furthermore, it has been recently described that strategies that reduce bone resorption and increase bone mineralization may decrease the risk of vascular calcifications; however, this approach still remains controversial. The mechanisms involved in vascular calcification are complex and not yet fully understood. Phosphorus plays a major role, while other factors related to bone formation have been recently identified.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Urinary Tract Calculi I: Introduction
Chronic Kidney Disease IV: Nursing Management

